Profit increased in the first quarter for Danish pharmaceutical company Novo Nordisk compared to the previous year. First-quarter net profit increased by 28% to 25.41 billion Danish kroner ($3 billion), the company reported. Earnings per share increased by 29% to 5.68 kroner. Operating profit increased by 27% in kroner and by 30% at constant exchange rates (CER) to 31.8 billion kroner. First quarter sales increased by 22% measured in kroner and by 24% at CER to 65.35 billion kroner in the first three months of 2024. For 2024, the company now expects operating profit growth to be 22% to 30% at …